Jonathan Boldt - Inovalon Holdings Vice President - Finance

INOV Etf  USD 28.03  0.05  0.18%   
Jonathan Boldt is Portfolio Manager at Inovalon Holdings
Mr. Jonathan Boldt CPA, is Chief Financial Officer of the Company. Mr. Boldt has served as our Chief Financial Officer since January 14, 2019. Mr. Boldt previously served as the Companys interim Chief Financial Officer and Vice President of Finance for corporate financial planning and analysis since March 16, 2018. As Chief Financial Officer, Mr. Boldt is responsible for the management, planning, implementation and execution of all financial activities, forecasting, reporting, audit, treasury, tax, and related compliance obligations of the Company. Since joining the Company in 2012, Mr. Boldt has served in numerous expanding financial positions playing integral roles in the Companys Initial Public Offering in 2015, and the acquisitions of Avalere Health, Inc. in 2015, Creehan Holding Co., Inc. in 2016, and ABILITY Network Inc. and its associated term loan financing facility in 2018. Prior to joining the Company in 2012, Mr. Boldt served in a number of escalating roles at Deloitte Touche, LLP, ultimately holding the position of attestation manager for public and private, domestic and international clients in information technology, government contracting, professional services, and manufacturing industries at various growth stages and scale ranging from 200 million to 20 billion in annual revenue. Mr. Boldt graduated magna cum laude from Loyola University in Maryland with a Bachelor degree in accounting and a masters of business administration degree with an information technologies concentration. He serves on the Loyola University of Maryland Sellinger School of Business Joint Advisory Board. Mr. Boldt is an active certified public accountant in the State of Maryland, a status which he has held since 2008.
Age 33
Tenure 5 years
Professional MarksCPA
Address 4321 Collington Road, Bowie, MD, United States, 20716
Phone(215) 979-3750
Webhttp://www.inovalon.com
IssuerInnovator Capital Management
Inception Date2023-11-01
BenchmarkiShares MSCI EAFE ETF
Entity TypeRegulated Investment Company
Asset Under Management3.49 Million
Asset TypeEquity
CategoryStrategy
FocusDeveloped Markets Basket
Market ConcentrationDeveloped Markets
RegionGlobal ex-North America
Boldt graduated magna cum laude from Loyola University in Maryland with a bachelor degree in accounting and a masters of business administration degree with an information technologies concentration. He serves on the Loyola University of Maryland Sellinger School of Business Joint Advisory Board.

Inovalon Holdings Management Efficiency

The company has return on total asset (ROA) of 0.0331 % which means that it generated a profit of $0.0331 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0716 %, meaning that it created $0.0716 on every $100 dollars invested by stockholders. Inovalon Holdings' management efficiency ratios could be used to measure how well Inovalon Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 897.3 M in liabilities with Debt to Equity (D/E) ratio of 1.39, which is about average as compared to similar companies. Inovalon Holdings has a current ratio of 2.13, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Inovalon Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Inovalon Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Inovalon Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Inovalon to invest in growth at high rates of return. When we think about Inovalon Holdings' use of debt, we should always consider it together with cash and equity.

Similar Fund Executives

Showing other executives

One Year Return

AmirAli TalasazGuardant Health
44
Yaron ZilbermanMedigus Ltd ADR
42
Michael PhillipsCigna Corp
N/A
Lisa UthgenanntLaboratory
57
David EricksonEdwards Lifesciences Corp
N/A
John MurabitoCigna Corp
62
Herbert FritchCigna Corp
64
Stephen FarberMednax Inc
49
CHRISTOPHER HOCEVARCigna Corp
43
Christopher MBACigna Corp
N/A
JeanLuc LemercierEdwards Lifesciences Corp
67
Brian CaveneyLaboratory
47
Dominic AndreanoMednax Inc
52
William McDowellCigna Corp
N/A
Scott UllemEdwards Lifesciences Corp
57
Kevin SmithMednax Inc
N/A
Kristen LauriaCigna Corp
51
David GuilmetteCigna Corp
51
Jason SadlerCigna Corp
55
Samuel EbertsLaboratory
57
Mark BoxerCigna Corp
59
Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland. Inovalon Hlds operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 1836 people. Inovalon Holdings [INOV] is traded in USA and was established null. Inovalon Holdings is listed under Health Care Technology category by Fama And French industry classification.

Management Performance

Inovalon Holdings Money Managers

Paige MD, Chief Officer
Keith Dunleavy, Chairman of the Board, CEO
June Duchesne, Chief Legal Officer and Corporate Secretary
Jason Rosenberg, Chief Strategic Development Officer
Kim Collins, Sr Communications
Jason Capitel, COO
Eron Kelly, Co Pres
Denise Fletcher, Independent Director
Ingrid Olsen, Chief Officer
Thomas Kloster, CFO
Daniel Mendelson, President of Avalere Health
Christopher Greiner, Chief Product and Operations Officer
Joseph Rostock, CTO
Andre Hoffmann, Independent Director
William Green, Director
Beverly Allen, Chief Counsel
Lee Roberts, Independent Director
Shauna Vernal, Chief Legal Officer and Corporate Secretary
Eric Sullivan, VP Strategies
Mark Pulido, Independent Director
Hulus Alpay, VP Relations
Jonathan Boldt, Vice President - Finance
Geoff Charron, Chief Officer
Daniel Rizzo, Chief Innovation Officer
John Burgin, Chief Product Officer
Robert Wychulis, President
Isaac Kohane, Director
Peter Bock, Chief Administrative Officer
William Teuber, Independent Director
Jonathan CPA, Chief Officer
Christopher Hand, Chief Growth Officer

Inovalon Etf Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is Inovalon Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inovalon Holdings. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Inovalon Etf please use our How to Invest in Inovalon Holdings guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Inovalon Etf analysis

When running Inovalon Holdings' price analysis, check to measure Inovalon Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovalon Holdings is operating at the current time. Most of Inovalon Holdings' value examination focuses on studying past and present price action to predict the probability of Inovalon Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inovalon Holdings' price. Additionally, you may evaluate how the addition of Inovalon Holdings to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Commodity Directory
Find actively traded commodities issued by global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
The market value of Inovalon Holdings is measured differently than its book value, which is the value of Inovalon that is recorded on the company's balance sheet. Investors also form their own opinion of Inovalon Holdings' value that differs from its market value or its book value, called intrinsic value, which is Inovalon Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovalon Holdings' market value can be influenced by many factors that don't directly affect Inovalon Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovalon Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovalon Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovalon Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.